Copyright Reports & Markets. All rights reserved.

Global Drug-Eluting Stent Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drug-Eluting Stent Market Overview

      • 1.1 Product Overview and Scope of Drug-Eluting Stent
      • 1.2 Drug-Eluting Stent Segment by Type
        • 1.2.1 Global Drug-Eluting Stent Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 ZES-BP
        • 1.2.3 EES
        • 1.2.4 ZES
        • 1.2.5 SES
        • 1.2.6 PES
      • 1.3 Drug-Eluting Stent Segment by Application
        • 1.3.1 Drug-Eluting Stent Consumption Comparison by Application (2014-2025)
        • 1.3.2 Cath labs
        • 1.3.3 Hospitals
        • 1.3.4 Ambulatory surgical centers (ASCs)
      • 1.4 Global Drug-Eluting Stent Market by Region
        • 1.4.1 Global Drug-Eluting Stent Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Drug-Eluting Stent Market Size
        • 1.5.1 Global Drug-Eluting Stent Revenue (2014-2025)
        • 1.5.2 Global Drug-Eluting Stent Production (2014-2025)

      2 Global Drug-Eluting Stent Market Competition by Manufacturers

      • 2.1 Global Drug-Eluting Stent Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drug-Eluting Stent Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drug-Eluting Stent Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drug-Eluting Stent Production Sites, Area Served, Product Types
      • 2.5 Drug-Eluting Stent Market Competitive Situation and Trends
        • 2.5.1 Drug-Eluting Stent Market Concentration Rate
        • 2.5.2 Drug-Eluting Stent Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drug-Eluting Stent Production Market Share by Regions

      • 3.1 Global Drug-Eluting Stent Production Market Share by Regions
      • 3.2 Global Drug-Eluting Stent Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drug-Eluting Stent Production
        • 3.4.1 North America Drug-Eluting Stent Production Growth Rate (2014-2019)
        • 3.4.2 North America Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drug-Eluting Stent Production
        • 3.5.1 Europe Drug-Eluting Stent Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drug-Eluting Stent Production (2014-2019)
        • 3.6.1 China Drug-Eluting Stent Production Growth Rate (2014-2019)
        • 3.6.2 China Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drug-Eluting Stent Production (2014-2019)
        • 3.7.1 Japan Drug-Eluting Stent Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drug-Eluting Stent Consumption by Regions

      • 4.1 Global Drug-Eluting Stent Consumption by Regions
      • 4.2 North America Drug-Eluting Stent Consumption (2014-2019)
      • 4.3 Europe Drug-Eluting Stent Consumption (2014-2019)
      • 4.4 China Drug-Eluting Stent Consumption (2014-2019)
      • 4.5 Japan Drug-Eluting Stent Consumption (2014-2019)

      5 Global Drug-Eluting Stent Production, Revenue, Price Trend by Type

      • 5.1 Global Drug-Eluting Stent Production Market Share by Type (2014-2019)
      • 5.2 Global Drug-Eluting Stent Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drug-Eluting Stent Price by Type (2014-2019)
      • 5.4 Global Drug-Eluting Stent Production Growth by Type (2014-2019)

      6 Global Drug-Eluting Stent Market Analysis by Applications

      • 6.1 Global Drug-Eluting Stent Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drug-Eluting Stent Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drug-Eluting Stent Business

      • 7.1 Abbott Laboratories
        • 7.1.1 Abbott Laboratories Drug-Eluting Stent Production Sites and Area Served
        • 7.1.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.1.3 Abbott Laboratories Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Biosensors International Group
        • 7.2.1 Biosensors International Group Drug-Eluting Stent Production Sites and Area Served
        • 7.2.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.2.3 Biosensors International Group Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Boston Scientific
        • 7.3.1 Boston Scientific Drug-Eluting Stent Production Sites and Area Served
        • 7.3.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.3.3 Boston Scientific Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Medtronic
        • 7.4.1 Medtronic Drug-Eluting Stent Production Sites and Area Served
        • 7.4.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.4.3 Medtronic Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Terumo Corporation
        • 7.5.1 Terumo Corporation Drug-Eluting Stent Production Sites and Area Served
        • 7.5.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.5.3 Terumo Corporation Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Biotronik
        • 7.6.1 Biotronik Drug-Eluting Stent Production Sites and Area Served
        • 7.6.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.6.3 Biotronik Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Cook Medical
        • 7.7.1 Cook Medical Drug-Eluting Stent Production Sites and Area Served
        • 7.7.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.7.3 Cook Medical Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Envision Scientific
        • 7.8.1 Envision Scientific Drug-Eluting Stent Production Sites and Area Served
        • 7.8.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.8.3 Envision Scientific Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Lepu Medical
        • 7.9.1 Lepu Medical Drug-Eluting Stent Production Sites and Area Served
        • 7.9.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.9.3 Lepu Medical Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Meril Life Sciences
        • 7.10.1 Meril Life Sciences Drug-Eluting Stent Production Sites and Area Served
        • 7.10.2 Drug-Eluting Stent Product Introduction, Application and Specification
        • 7.10.3 Meril Life Sciences Drug-Eluting Stent Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 MicroPort Medical
      • 7.12 Opto Circuits
      • 7.13 Shandong JW Medical Systems
      • 7.14 STENTYS

      8 Drug-Eluting Stent Manufacturing Cost Analysis

      • 8.1 Drug-Eluting Stent Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drug-Eluting Stent
      • 8.4 Drug-Eluting Stent Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drug-Eluting Stent Distributors List
      • 9.3 Drug-Eluting Stent Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drug-Eluting Stent Market Forecast

      • 11.1 Global Drug-Eluting Stent Production, Revenue Forecast
        • 11.1.1 Global Drug-Eluting Stent Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drug-Eluting Stent Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drug-Eluting Stent Price and Trend Forecast (2019-2025)
      • 11.2 Global Drug-Eluting Stent Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drug-Eluting Stent Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drug-Eluting Stent Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drug-Eluting Stent Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drug-Eluting Stent Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drug-Eluting Stent Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drug-Eluting Stent Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drug-Eluting Stent Consumption Forecast (2019-2025)
        • 11.3.3 China Drug-Eluting Stent Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drug-Eluting Stent Consumption Forecast (2019-2025)
      • 11.4 Global Drug-Eluting Stent Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drug-Eluting Stent Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body’s natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.
        The growing prevalence of these diseases is due to factors such as smoking, obesity, alcohol consumption, and unhealthy lifestyle. Furthermore, the rapidly increasing older population is driving the market because aging increase the chances of developing cardiovascular diseases including atherosclerosis.
        The global market for the drug-eluting stent is highly fragmented due to the presence of several well-established vendors. The competition is expected to intensify with an increase in product portfolio extensions with next-generation products, technological innovations, and mergers and acquisitions.

        The global Drug-Eluting Stent market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drug-Eluting Stent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug-Eluting Stent market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Abbott Laboratories
        Biosensors International Group
        Boston Scientific
        Medtronic
        Terumo Corporation
        Biotronik
        Cook Medical
        Envision Scientific
        Lepu Medical
        Meril Life Sciences
        MicroPort Medical
        Opto Circuits
        Shandong JW Medical Systems
        STENTYS

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        ZES-BP
        EES
        ZES
        SES
        PES

        Segment by Application
        Cath labs
        Hospitals
        Ambulatory surgical centers (ASCs)

        Buy now